1. Home
  2. IRDM vs ACAD Comparison

IRDM vs ACAD Comparison

Compare IRDM & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRDM
  • ACAD
  • Stock Information
  • Founded
  • IRDM 2000
  • ACAD 1993
  • Country
  • IRDM United States
  • ACAD United States
  • Employees
  • IRDM N/A
  • ACAD N/A
  • Industry
  • IRDM Telecommunications Equipment
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRDM Telecommunications
  • ACAD Health Care
  • Exchange
  • IRDM Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • IRDM 3.3B
  • ACAD 3.5B
  • IPO Year
  • IRDM N/A
  • ACAD 2004
  • Fundamental
  • Price
  • IRDM $24.18
  • ACAD $23.53
  • Analyst Decision
  • IRDM Buy
  • ACAD Buy
  • Analyst Count
  • IRDM 5
  • ACAD 18
  • Target Price
  • IRDM $33.20
  • ACAD $27.94
  • AVG Volume (30 Days)
  • IRDM 2.1M
  • ACAD 1.7M
  • Earning Date
  • IRDM 07-24-2025
  • ACAD 08-06-2025
  • Dividend Yield
  • IRDM 2.48%
  • ACAD N/A
  • EPS Growth
  • IRDM 42.40
  • ACAD N/A
  • EPS
  • IRDM 1.00
  • ACAD 1.37
  • Revenue
  • IRDM $857,546,000.00
  • ACAD $996,283,000.00
  • Revenue This Year
  • IRDM $7.65
  • ACAD $13.28
  • Revenue Next Year
  • IRDM $3.56
  • ACAD $10.88
  • P/E Ratio
  • IRDM $24.09
  • ACAD $17.19
  • Revenue Growth
  • IRDM 7.56
  • ACAD 22.42
  • 52 Week Low
  • IRDM $19.91
  • ACAD $13.40
  • 52 Week High
  • IRDM $35.85
  • ACAD $25.23
  • Technical
  • Relative Strength Index (RSI)
  • IRDM 27.71
  • ACAD 61.47
  • Support Level
  • IRDM $24.61
  • ACAD $22.40
  • Resistance Level
  • IRDM $32.64
  • ACAD $24.06
  • Average True Range (ATR)
  • IRDM 1.26
  • ACAD 0.72
  • MACD
  • IRDM -0.90
  • ACAD 0.09
  • Stochastic Oscillator
  • IRDM 3.38
  • ACAD 76.96

About IRDM Iridium Communications Inc

Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: